25 June 2020 - Campaign provides needed, fact-based, information for patients, healthcare providers and Canadians about biosimilar medicines in Canada.

Sandoz announced today the launch in Canada of The Biosimilars Generation campaign to help Canadians better understand the benefits of biosimilars, their proven safety and efficacy, and the opportunities they present to the healthcare system to realise savings and increase access to innovative new medicines.

The Biosimilars Generation is a starting point to facilitate discussion around biosimilars and inform a generation of Canadians interested in helping sustain our healthcare system. Through increased awareness, the campaign seeks to provide fact and evidence-based information and education to patients, healthcare providers and all Canadians about biosimilar medicines.

Read Sandoz press release